Literature DB >> 12453046

Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons.

Sangmi Chung1, Kai-C Sonntag, Therese Andersson, Lars M Bjorklund, Jae-Joon Park, Dong-Wook Kim, Un Jung Kang, Ole Isacson, Kwang-Soo Kim.   

Abstract

Nurr1 is a transcription factor critical for the development of midbrain dopaminergic (DA) neurons. This study modified mouse embryonic stem (ES) cells to constitutively express Nurr1 under the elongation factor-1alpha promoter. The Nurr1-expression in ES cells lead to up-regulation of all DA neuronal markers tested, resulting in about a 4- to 5-fold increase in the proportion of DA neurons. In contrast, other neuronal and glial markers were not significantly changed by Nurr1 expression. It was also observed that there was an additional 4-fold increase in the number of DA neurons in Nurr1-expressing clones following treatment with Shh, FGF8 and ascorbic acid. Several lines of evidence suggest that these neurons may represent midbrain DA neuronal phenotypes; firstly, they coexpress midbrain DA markers such as aromatic L-amino acid decarboxylase, calretinin, and dopamine transporter, in addition to tyrosine hydroxylase and secondly, they do not coexpress other neurotransmitters such as GABA or serotonin. Finally, consistent with an increased number of DA neurons, the Nurr1 transduction enhanced the ability of these neurons to produce and release DA in response to membrane depolarization. This study demonstrates an efficient genetic manipulation of ES cells that facilitates differentiation to midbrain DA neurons, and it will serve as a framework of genetic engineering of ES cells by key transcription factor to regulate their cell fate.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12453046      PMCID: PMC2610444          DOI: 10.1046/j.1460-9568.2002.02255.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  49 in total

1.  A homeodomain gene Ptx3 has highly restricted brain expression in mesencephalic dopaminergic neurons.

Authors:  M P Smidt; H S van Schaick; C Lanctôt; J J Tremblay; J J Cox; A A van der Kleij; G Wolterink; J Drouin; J P Burbach
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

2.  Role of aromatic L-amino acid decarboxylase for dopamine replacement by genetically modified fibroblasts in a rat model of Parkinson's disease.

Authors:  S R Wachtel; C Bencsics; U J Kang
Journal:  J Neurochem       Date:  1997-11       Impact factor: 5.372

3.  Cellular expression of the immediate early transcription factors Nurr1 and NGFI-B suggests a gene regulatory role in several brain regions including the nigrostriatal dopamine system.

Authors:  R H Zetterström; R Williams; T Perlmann; L Olson
Journal:  Brain Res Mol Brain Res       Date:  1996-09-05

4.  Differential regulation of transcription by the NURR1/NUR77 subfamily of nuclear transcription factors.

Authors:  E P Murphy; A D Dobson; C Keller; O M Conneely
Journal:  Gene Expr       Date:  1996

5.  Single factors direct the differentiation of stem cells from the fetal and adult central nervous system.

Authors:  K K Johe; T G Hazel; T Muller; M M Dugich-Djordjevic; R D McKay
Journal:  Genes Dev       Date:  1996-12-15       Impact factor: 11.361

6.  Dopamine biosynthesis is selectively abolished in substantia nigra/ventral tegmental area but not in hypothalamic neurons in mice with targeted disruption of the Nurr1 gene.

Authors:  S O Castillo; J S Baffi; M Palkovits; D S Goldstein; I J Kopin; J Witta; M A Magnuson; V M Nikodem
Journal:  Mol Cell Neurosci       Date:  1998-05       Impact factor: 4.314

7.  Development of neuronal precursor cells and functional postmitotic neurons from embryonic stem cells in vitro.

Authors:  S Okabe; K Forsberg-Nilsson; A C Spiro; M Segal; R D McKay
Journal:  Mech Dev       Date:  1996-09       Impact factor: 1.882

8.  Blastula-stage stem cells can differentiate into dopaminergic and serotonergic neurons after transplantation.

Authors:  T Deacon; J Dinsmore; L C Costantini; J Ratliff; O Isacson
Journal:  Exp Neurol       Date:  1998-01       Impact factor: 5.330

9.  Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons.

Authors:  O Saucedo-Cardenas; J D Quintana-Hau; W D Le; M P Smidt; J J Cox; F De Mayo; J P Burbach; O M Conneely
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

10.  Dopamine neuron agenesis in Nurr1-deficient mice.

Authors:  R H Zetterström; L Solomin; L Jansson; B J Hoffer; L Olson; T Perlmann
Journal:  Science       Date:  1997-04-11       Impact factor: 47.728

View more
  60 in total

1.  Temporally induced Nurr1 can induce a non-neuronal dopaminergic cell type in embryonic stem cell differentiation.

Authors:  Kai-Christian Sonntag; Rabi Simantov; Kwang-Soo Kim; Ole Isacson
Journal:  Eur J Neurosci       Date:  2004-03       Impact factor: 3.386

2.  Expression patterns of Nurr1 in rat retina development.

Authors:  Yingmin Li; Qian Qi; Bin Cong; Weibo Shi; Xia Liu; Guozhong Zhang; Chunling Ma
Journal:  J Mol Histol       Date:  2012-06-20       Impact factor: 2.611

Review 3.  Midbrain dopaminergic development in vivo and in vitro from embryonic stem cells.

Authors:  Sarah L Maxwell; Meng Li
Journal:  J Anat       Date:  2005-09       Impact factor: 2.610

4.  Efficient production of mesencephalic dopamine neurons by Lmx1a expression in embryonic stem cells.

Authors:  Stina Friling; Elisabet Andersson; Lachlan H Thompson; Marie E Jönsson; Josephine B Hebsgaard; Evanthia Nanou; Zhanna Alekseenko; Ulrika Marklund; Susanna Kjellander; Nikolaos Volakakis; Outi Hovatta; Abdeljabbar El Manira; Anders Björklund; Thomas Perlmann; Johan Ericson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-21       Impact factor: 11.205

Review 5.  Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects.

Authors:  Kai-C Sonntag; Bin Song; Nayeon Lee; Jin Hyuk Jung; Young Cha; Pierre Leblanc; Carolyn Neff; Sek Won Kong; Bob S Carter; Jeffrey Schweitzer; Kwang-Soo Kim
Journal:  Prog Neurobiol       Date:  2018-04-11       Impact factor: 11.685

Review 6.  Establishment and therapeutic use of human embryonic stem cell lines.

Authors:  Hirofumi Suemori
Journal:  Hum Cell       Date:  2006-05       Impact factor: 4.174

7.  A tyrosine hydroxylase-yellow fluorescent protein knock-in reporter system labeling dopaminergic neurons reveals potential regulatory role for the first intron of the rodent tyrosine hydroxylase gene.

Authors:  B B Kelly; E Hedlund; C Kim; H Ishiguro; O Isacson; D M Chikaraishi; K-S Kim; G Feng
Journal:  Neuroscience       Date:  2006-07-31       Impact factor: 3.590

8.  Stem cell grafting improves both motor and cognitive impairments in a genetic model of Parkinson's disease, the aphakia (ak) mouse.

Authors:  Jisook Moon; Hyun-Seob Lee; Jun Mo Kang; Junpil Park; Amanda Leung; Sunghoi Hong; Sangmi Chung; Kwang-Soo Kim
Journal:  Cell Transplant       Date:  2012-10-02       Impact factor: 4.064

9.  Formation of embryoid bodies from mouse embryonic stem cells cultured on silicon-coated surfaces.

Authors:  Fardin Fathi; Taki Altiraihi; Seyed Javad Mowla; Mansoreh Movahedin
Journal:  Cytotechnology       Date:  2009-03-18       Impact factor: 2.058

10.  Wnt1-lmx1a forms a novel autoregulatory loop and controls midbrain dopaminergic differentiation synergistically with the SHH-FoxA2 pathway.

Authors:  Sangmi Chung; Amanda Leung; Baek-Soo Han; Mi-Yoon Chang; Jung-Il Moon; Chun-Hyung Kim; Sunghoi Hong; Jan Pruszak; Ole Isacson; Kwang-Soo Kim
Journal:  Cell Stem Cell       Date:  2009-12-04       Impact factor: 24.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.